You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A Phase 1/2 Randomized, Dose-Finding Study of MEDI-551 in Subjects with Relapsing-Remitting Multiple Sclerosis
- Disease
- multiple sclerosis
- Drug Name
- MEDI-551
- Generic Name
- MEDI-551
- Sponsor
- MedImmune
- Drug Status
- In Development
- Phase
- I/II
- Start Date
- May 1, 2012
- Study Name
- CD-IA-MEDI-551-1102
- Study Id
- CD-IA-MEDI-551-1102
- ClinicalTrials.gov ID
- NCT01585766
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
